Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus |
| |
Authors: | Yuichiro Fujieda Hiroshi Kataoka Toshio Odani Kotaro Otomo Masaru Kato Shinji Fukaya Kenji Oku Tetsuya Horita Shinsuke Yasuda Tatsuya Atsumi Takao Koike |
| |
Affiliation: | Department of Medicine II, Hokkaido University Graduate School of Medicine, N15W7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan. edaichi@med.hokudai.ac.jp |
| |
Abstract: | To characterize reversible posterior leukoencephalopathy syndrome (RPLS) in systemic lupus erythematosus (SLE) in terms of treatments for resolution and its clinical course, we reviewed 28 cases of RPLS in SLE including our cases in view of the treatment. Of these, 15 cases improved with blood pressure control and 13 required immunosuppressive therapy for activity of SLE presenting neurological manifestations. Patients without immunosuppressants at onset of RPLS more frequently required immunosuppressive therapy to recover it than those precedingly using these agents 31% (4/13) versus 87% (13/15), p = 0.008, chi-square test]. Brain magnetic resonance imaging (MRI) is important for diagnosis of RPLS-SLE in the patient with SLE who develops neurological disturbance and rapidly increasing blood pressure. When 7-day therapy for hypertension and convulsion does not reverse the manifestations, immunosuppressive treatments would be recommended to reverse RPLS. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|